What do you monitor?
Curated feeds for your role. Pick your area and get exactly the sources you need.
Compliance & Legal
Legal Research
Court opinions, regulatory guidance, and enforcement actions. AI-summarized.
Financial Compliance
SEC, OCC, FDIC, Fed, FINRA, CFPB, FASB, and state banking regulators. One feed.
Insurance Compliance
State commissioner bulletins, NAIC model laws, and DOI enforcement actions.
Environmental Compliance
EPA enforcement, state environmental agencies, PFAS regulatory updates.
Data Privacy
State AG privacy enforcement, FTC actions, CPPA rulemaking, and HIPAA enforcement.
Tax Compliance
IRS guidance changes and state tax department bulletins.
AML Compliance
FinCEN, OCC, FDIC, Fed, FATF, and banking regulator enforcement.
Labor & Employment
NLRB decisions, EEOC guidance, DOL wage updates, and 50-state labor law changes.
Immigration Law
USCIS policy changes, visa bulletin updates, CBP processing changes.
Industry
Pharma & Life Sciences
FDA warning letters, drug approvals, ICH guidelines, EMA updates, and DEA scheduling.
Energy & Utilities
FERC orders, state PUC decisions, and energy regulatory changes.
Cybersecurity
CISA KEV catalog, ICS-CERT, NSA advisories, NIST CSF, and FedRAMP updates.
Healthcare Compliance
CMS transmittals, OIG work plan, HIPAA enforcement, and Medicaid updates.
Trade & Procurement
Recent changes
FDA Guidance on Promotional Labeling for Biosimilar Products
The FDA has issued new guidance addressing promotional labeling and advertising considerations for prescription reference products, biosimilar products, and interchangeable biosimilar products. The guidance aims to ensure promotional communications are accurate, truthful, and non-misleading for manufacturers and their representatives.
FDA Finalizes Guidance on Drug Dispute Resolution
The FDA has finalized guidance for industry on formal dispute resolution and administrative hearings for drugs subject to final administrative orders under section 505G of the FD&C Act. This guidance provides recommendations for resolving scientific and medical disputes between the Center for Drug Evaluation and Research (CDER) and drug sponsors.
FDA Draft Guidance on Bayesian Methodology in Drug Trials
The FDA has issued draft guidance on the use of Bayesian methodology in clinical trials for drug and biological products. This guidance is intended for sponsors and applicants and focuses on supporting primary inference for effectiveness and safety. The agency is seeking public comments on this draft document.
FDA Draft Guidance: Common Technical Document for Quality
The FDA has released draft guidance on the Common Technical Document (CTD) for the quality section of pharmaceutical registration applications. This guidance, developed under the International Council for Harmonisation (ICH), aims to harmonize the organization and presentation of quality data for human use pharmaceuticals. Comments on the draft are due by March 23, 2026.
FDA Draft Guidance on Patient Preference Studies
The FDA has released draft guidance on general considerations for patient preference studies, developed under the International Council for Harmonisation (ICH). The agency is accepting public comments on this draft guidance until April 7, 2026.
Bartholomew v. Parking Concepts, Inc. - Civil Litigation
This document pertains to the civil case Bartholomew v. Parking Concepts, Inc., case number A171546, filed in a US court. The filing represents a new addition to the court's docket, initiating legal proceedings between the named parties.
Esparza v. Superior Court Case Information
This notice provides case information for Esparza v. Superior Court, identified by case number E085807. The update is from the California Courts Appellate Cases system. No specific compliance actions or deadlines are detailed.
Gerard v. Cuevas - Unlawful Detainer Rent Case Opinion
This document is an opinion from a California court regarding an unlawful detainer rent case, Gerard v. Cuevas. It provides a judicial interpretation of relevant housing and landlord-tenant laws.
Engstrom v. United States - Sentencing Reversed
The Ninth Circuit Court of Appeals reversed the sentencing of Paul Engstrom in a drug case. The court found that the district court erred in its application of sentencing enhancements, requiring a resentencing. This decision impacts how certain drug offenses are sentenced within the Ninth Circuit.
Montejo-Gonzalez v. Bondi - Immigration Habeas Corpus
The Ninth Circuit Court of Appeals issued an opinion in Montejo-Gonzalez v. Bondi, addressing a habeas corpus petition related to immigration detention. The court's decision clarifies legal standards applicable to such cases.
Browse by category
US Federal
325 sources
US State
192 sources
UK
42 sources
EU
40 sources
Canada
9 sources
State Courts
91 sources
Drug Safety
45 sources
Financial Regulation
43 sources
Legislation
42 sources
Trade & Export
36 sources
Federal Courts
25 sources
Data Protection
21 sources
Energy Regulation
13 sources
Securities Regulation
6 sources
Consumer Protection
5 sources
Insurance Regulation
5 sources
Attorneys General
3 sources
Environment
3 sources
Competition
2 sources
Labor & Employment
2 sources
Tax
1 sources
Get alerts when regulations change
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.